Intra-abdominal infections (IAI) are among the most common global healthcare challenges
and they are usually precipitated by disruption to the gastrointestinal (GI) tract. Their …

Carbapenem resistance is a major global health problem that seriously compromises the
treatment of infections caused by nosocomial pathogens. Resistance to carbapenems …

Classical resistance classifications (multidrug resistance [MDR], extensive drug resistance
[XDR], pan-drug resistance [PDR]) are very useful for epidemiological purposes, however …

Purpose This article is the first to review published reports on the prevalence of multidrug-
resistant (MDR) gram-negative infections in Egypt and gain insights into antimicrobial …

Antimicrobial resistance represents a serious threat for global health, causing an
unacceptable burden in terms of morbidity, mortality and healthcare costs. In particular, in …

Background We isolated the carbapenemase-producing Enterobacteriaceae (CPE) strains
from children during 2016–2021 in Shanghai, China and investigated the antimicrobial …

Temocillin is an old antibiotic, but given its particular characteristics, it may be a suitable
alternative to carbapenems for treating infections due to ESBL-producing Enterobacterales …

Ceftobiprole combines an excellent spectrum for community-acquired pneumonia (CAP)
and hospital-acquired pneumonia (HAP) pathogens, with a low/medium MDR risk, and the β …

Abstract Objectives Bloodstream infections (BSIs) caused by extended-spectrum beta-
lactamase-producing Enterobacteriaceae (ESBL-PE) have become a worldwide public …

This systematic review was conducted to compare the efficacy of non-carbapenem β-
lactam/β-lactamase inhibitors (BLBLIs) versus carbapenems for the treatment of urinary tract …